 Alcon AG NYSE: ALC reported second-quarter FY21 sales of 2.1 billion, 75 YY on a reported basis and 69 on a constant currency basis, beating the consensus of 1.96 billion. All categories benefited from the improvements in the eye care market, led by the strong recovery in the U.S. and varied paces of recovery in international markets from the COVID-19 pandemic. 